Patent ID: 11958856
Assignee: JANSSEN PHARMACEUTICA NV
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 14:
15. The method of claim 12, wherein the thromboembolic disorder is selected from the group consisting of an acute coronary syndrome, arterial embolism, atherosclerosis, atrial fibrillation, cerebral arterial thrombosis, cerebral embolism, coronary arterial thrombosis, deep vein thrombosis, first myocardial infarction, ischemic sudden death, kidney embolism, peripheral occlusive arterial disease, pulmonary embolism, recurrent myocardial infarction, stroke, thrombophlebitis, thrombosis resulting from cardiopulmonary bypass, thrombosis resulting from hemodialysis, thrombosis resulting from an implant, thrombosis resulting from an indwelling catheter, thrombosis resulting from a prosthetic valve, thrombosis resulting from a stent, transient ischemic attack, unstable angina, and venous thrombosis.